06/26/2025
3:16 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
3:30 PM | Crinetics Pharmaceuticals (Filer)
| Form DEF 14A | |
04/23/2025
3:33 PM | Crinetics Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2025
3:36 PM | Crinetics Pharmaceuticals (Filer)
| Form ARS | |
04/07/2025
10:52 AM | Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
03/21/2025
5:31 PM | Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
5:32 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
5:33 PM | Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
5:34 PM | Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:30 PM | Crinetics Pharmaceuticals (Issuer)
Schilke Tobin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/27/2025
3:23 PM | Crinetics Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Get the Latest News and Ratings for CRNX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
02/27/2025
3:23 PM | Crinetics Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2025
3:10 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
3:13 PM | Crinetics Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/24/2025
7:50 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2025
9:25 AM | Crinetics Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025
9:06 AM | Crinetics Pharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025
9:23 AM | Crinetics Pharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
01/30/2025
8:33 PM | Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/29/2025
3:30 PM | Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/29/2025
3:30 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/14/2025
4:02 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
3:30 PM | Crinetics Pharmaceuticals (Issuer)
Kalofonos Isabel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
6:34 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:30 PM | Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:30 PM | Crinetics Pharmaceuticals (Issuer)
Kalofonos Isabel (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/18/2024
3:30 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:32 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
7:07 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2024
3:06 PM | Crinetics Pharmaceuticals (Subject)
Struthers Richard Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
3:30 PM | Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
6:55 PM | Crinetics Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:46 PM | Crinetics Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
11/12/2024
1:26 PM | Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Crinetics Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
11/04/2024
10:20 AM | Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/17/2024
11:47 AM | Crinetics Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/16/2024
3:08 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
4:13 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
3:35 PM | Crinetics Pharmaceuticals (Filer)
| Form 424B5 | |
10/08/2024
4:01 PM | Crinetics Pharmaceuticals (Filer)
| Form 424B5 | |
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad) Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.”
We recently sat down with Rickards to capture all the key details on tape.
 For the moment, you can watch this interview free of charge – just click here. |
10/07/2024
6:55 AM | Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:01 PM | Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/26/2024
3:23 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
3:06 PM | Crinetics Pharmaceuticals (Subject)
Wilson Marc (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:30 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
11:11 AM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
3:31 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
12:16 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
10:35 AM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/26/2024
3:38 PM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
3:04 PM | Crinetics Pharmaceuticals (Subject)
Wilson Marc (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024
9:54 AM | Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
